CXCR1 and CXCR2-overexpressing tumours show an increased proliferation of melanoma cells and increased microvessel density, with evidence of reduced apoptosis in both cell lines in in vitro and in vivo models [26,27,28,29]. The gene discussed is CXCR2; the disease is neoplasm.